Canada markets open in 2 hours 38 minutes
  • S&P/TSX

    20,693.79
    +140.54 (+0.68%)
     
  • S&P 500

    4,480.70
    +37.65 (+0.85%)
     
  • DOW

    34,814.39
    +236.82 (+0.68%)
     
  • CAD/USD

    0.7914
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    72.55
    -0.06 (-0.08%)
     
  • BTC-CAD

    60,646.99
    +191.70 (+0.32%)
     
  • CMC Crypto 200

    1,232.60
    +35.39 (+2.96%)
     
  • GOLD FUTURES

    1,780.60
    -14.20 (-0.79%)
     
  • RUSSELL 2000

    2,234.45
    +24.46 (+1.11%)
     
  • 10-Yr Bond

    1.3040
    0.0000 (0.00%)
     
  • NASDAQ futures

    15,470.50
    -33.50 (-0.22%)
     
  • VOLATILITY

    18.61
    -0.85 (-4.37%)
     
  • FTSE

    7,049.26
    +32.77 (+0.47%)
     
  • NIKKEI 225

    30,323.34
    -188.37 (-0.62%)
     
  • CAD/EUR

    0.6725
    +0.0024 (+0.36%)
     

The Law Offices of Frank R. Cruz Announces Investigation of Zymergen Inc. (ZY) on Behalf of Investors

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

LOS ANGELES, August 04, 2021--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On August 3, 2021, after the market closed, Zymergen issued a business update stating that it "recently became aware of issues with its commercial product pipeline that will impact the Company’s delivery timeline and revenue projections." As a result, Zymergen "no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022." The Company also announced that its Chief Executive Officer, Josh Hoffman, was stepping down, effective immediately.

On this news, the Company’s share price fell as much as 70% in afterhours trading on August 3, 2021, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Zymergen securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210803006178/en/

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting